BK20211065/Natural Science Foundation of Jiangsu Province[Grants and Funding] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

Efficacy and safety of bispecific antibodies vs. immune checkpoint blockade combination therapy in cancer: a real-world comparison.

Cheng L, Chen L, Shi Y, Gu W, Ding W, Zheng X, Liu Y, Jiang J, Zheng Z. Cheng L, et al. Mol Cancer. 2024 Apr 16;23(1):77. doi: 10.1186/s12943-024-01956-6. Mol Cancer. 2024. PMID: 38627681 Free PMC article. Review.

Microwave ablation combined with PD-L1 blockade synergistically promotes Cxcl9-mediated antitumor immunity.

He N, Huang H, Wu S, Ji W, Tai Y, Gao R, Liu Y, Liu Y, Chen L, Zhu D, Zheng X, Jiang J. He N, et al. Cancer Sci. 2024 Jul;115(7):2196-2208. doi: 10.1111/cas.16182. Epub 2024 Apr 24. Cancer Sci. 2024. PMID: 38655660 Free PMC article.

Enhanced abscopal anti-tumor response via a triple combination of thermal ablation, IL-21, and PD-1 inhibition therapy.

Wu S, Jiang H, Fang Z, Wu Y, Jiao J, Fang W, Wu Y, Lang Y, Chen N, Zhong Z, Chen L, Zheng X, Lu B, Jiang J. Wu S, et al. Cancer Immunol Immunother. 2024 Jun 4;73(8):138. doi: 10.1007/s00262-024-03718-1. Cancer Immunol Immunother. 2024. PMID: 38833177 Free PMC article.

Ferredoxin 1: a gatekeeper in halting lung adenocarcinoma progression through activation of the GPRIN2 signaling pathway.

Liu M, Wu S, Wu H, Zhou Y, Zhang X, Zhu D, Jiang J. Liu M, et al. J Transl Med. 2024 May 27;22(1):510. doi: 10.1186/s12967-024-05277-6. J Transl Med. 2024. PMID: 38802900 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4 results

Search Page

Filters